Docoh
Loading...

NVCN Neovasc

News

From Benzinga Pro
Neovasc Shares Spike Higher; Neovask Reducer System Receives National Reimbursement In France
30 Nov 21
News, FDA, Movers, Trading Ideas
Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the Neovasc Reducer™ ("Reducer") system has been granted Prise en Charge
Neovasc Says National Institute For Health And Care Excellence Of UK Provides Positive Guidance For Co's Reducer System
24 Nov 21
News
Neovasc Inc. (NASDAQ:NVCN) (TSX:NVCN) ("Neovasc" or the "Company") today announced that the United Kingdom's Interventional Procedures Programme at the National Institute for Health and
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
9 Nov 21
Biotech, Earnings, News, Penny Stocks, Guidance, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours:
Earnings Scheduled For November 9, 2021
9 Nov 21
Earnings, M&A, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter. • KT (NYSE:KT) is projected to report earnings for its third quarter.
Neovasc Says Co's Reducer Featured In Polish Heart Journal
21 Oct 21
News
Neovasc Inc. (NASDAQ:NVCN) (TSX:NVCN) ("Neovasc" or the "Company") today announced that the Neovasc Reducer™ ("Reducer") is featured in an article published
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
8 Oct 21
Biotech, News, Penny Stocks, Guidance, Offerings, Small Cap, FDA, IPOs, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7)
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
7 Oct 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6)
Neovasc Highlights Publication Of REDUCER-I Study In EuroIntervention Journal
28 Sep 21
Biotech, General
- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced the publication of an article entitled, "Coronary sinus narrowing for the treatment of refractory
Why Are Neovasc Shares Moving Higher On Thursday?
16 Sep 21
Long Ideas, News, Penny Stocks, Health Care, Movers, Trading Ideas, General

Press releases

From Benzinga Pro
Sidoti December Micro Cap Virtual Conference
7 Dec 21
Events, Press Releases
Presentation Times Released for 75+ Presenting CompaniesWednesday and Thursday, December 8-9, 2021NEW YORK, NY / ACCESSWIRE / December 7, 2021 / Sidoti & Company, LLC has released the presentation schedule and
Neovasc to Participate in Sidoti December Virtual Microcap Conference
1 Dec 21
Press Releases
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - December 1, 2021) - Neovasc Inc. (NASDAQ:NVCN) (TSX:NVCN) ("Neovasc" or the "Company") today announced that its management team will be
Neovasc Reducer(TM) System Receives National Reimbursement in France
30 Nov 21
Press Releases
First therapy to receive newly established French reimbursement designationVancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - November 30, 2021) - Neovasc Inc. (NASDAQ:NVCN)
Neovasc Reducer™ System Receives National Reimbursement in France
30 Nov 21
Press Releases, General
First therapy to receive newly established French reimbursement designation VANCOUVER and MINNEAPOLIS, Nov. 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX:
Neovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance
24 Nov 21
Press Releases
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - November 24, 2021) - Neovasc Inc. (NASDAQ:NVCN) (TSX:NVCN) ("Neovasc" or the "Company") has received written notification (the "Nasdaq
The National Institute for Health and Care Excellence of The United Kingdom Provides Positive Guidance for Neovasc Reducer System
24 Nov 21
Press Releases, General
VANCOUVER and MINNEAPOLIS, Nov. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the United Kingdom's Interventional Procedures
The National Institute for Health and Care Excellence of the United Kingdom Provides Positive Guidance for Neovasc Reducer System
24 Nov 21
Press Releases
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - November 24, 2021) - Neovasc Inc. (NASDAQ:NVCN) (TSX:NVCN) ("Neovasc" or the "Company") today announced that the United Kingdom's
Neovasc Announces Third Quarter 2021 Financial Results and Provides Corporate Update
9 Nov 21
Earnings, Press Releases
VANCOUVER and MINNEAPOLIS, Nov. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire --Neovasc, Inc.("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today reported financial results for the third quarter ended
Sidoti Microcap Virtual Conference
5 Nov 21
News, Press Releases
A Conference Open to All Classes of Investors70+ Companies Presenting and Meeting Interested Investors 1x1Wednesday and Thursday, December 8-9, 2021NEW YORK, NY / ACCESSWIRE / November 5, 2021 / Sidoti & Company, LLC
Neovasc to Report Third Quarter 2021 Financial Results on November 9, 2021
1 Nov 21
Press Releases
Vancouver, British Columbia--(Newsfile Corp. - November 1, 2021) - Neovasc Inc. (NASDAQ:NVCN) (TSX:NVCN), will report financial results for the quarter ended September 30, 2021 on Tuesday, November 9, 2021.
Neovasc Reducer™ Featured in Polish Heart Journal
21 Oct 21
Press Releases
Publication Highlights Device Success in Chronic Total Occlusions of the Right Coronary Artery VANCOUVER and MINNEAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the
Neovasc Reducer(TM) Featured in Polish Heart Journal
21 Oct 21
Press Releases
Publication Highlights Device Success in Chronic Total Occlusions of the Right Coronary ArteryVancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - October 21, 2021) - Neovasc Inc.
Neovasc REDUCER-I Study Published in EuroIntervention Journal
28 Sep 21
Press Releases
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - September 28, 2021) - Neovasc Inc. (NASDAQ:NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced the publication of an article
Neovasc to Participate in 2021 Benzinga Healthcare Small Cap Conference
23 Sep 21
Press Releases
VANCOUVER and MINNEAPOLIS, Sept. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ,TSX: NVCN) today announced that its management team will be participating in the 2021
Neovasc Announces FDA Approval of COSIRA-II Clinical Trial
16 Sep 21
Press Releases
Company on Schedule to Commence Trial Late This YearVancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - September 16, 2021) - Neovasc Inc. (NASDAQ:NVCN) (TSX:NVCN) ("Neovasc" or the "Company")